Buys
Open market- Shares
- Avg price
- Total value
Alan H. Auerbach - President and CEO, Director, 10%+ Owner at PUMA BIOTECHNOLOGY, INC.
Issuer-level insider activity
- Role
- President and CEO, Director, 10%+ Owner
- Issuer ticker
- PBYI on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Alan H. Auerbach in PUMA BIOTECHNOLOGY, INC.
Sells
Open market- Shares
- -79,008
- Avg price
- $7.20
- Total value
- -$568,929
Net
Past year- Shares
- -79,008
- Share %
- -100%
- Total value
- -$568,929
Reported holdings for Alan H. Auerbach in PUMA BIOTECHNOLOGY, INC.
Form 4 holding
President and CEO, Director, 10%+ Owner
PUMA BIOTECHNOLOGY, INC.
- Security class
- Common Stock
- Shares / value
- 7,261,671
- Estimated value
- $60,003,187
- Report date
- 06 Jul 2026
- Price
- $8.26
- Ownership
- Direct
Form 4 holding
President and CEO, Director, 10%+ Owner
PUMA BIOTECHNOLOGY, INC.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 227,474
- Estimated value
- Report date
- 18 Feb 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Alan H. Auerbach in PUMA BIOTECHNOLOGY, INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.